Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study

Circulation

Volumn 102, Issue 20, 2000, Pages 2466-2472

  Théroux, Pierre ^a   Alexander Jr , Joe ^b   Pharand, Chantal ^c   Barr, Eliav ^b   Snapinn, Steven ^b   Ghannam, Asma F ^b   Sax, Frederic L ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Angina; Diabetes mellitus; Glycoproteins; Myocardial infarction; Tirofiban

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE MB; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; ORAL ANTIDIABETIC AGENT; TIROFIBAN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS;

EID: 0034649326     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.20.2466     Document Type: Article

References (21)

1. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction
2. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
3. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
4. Outcomes of diabetic patients following acute myocardial infarction: A review of the major thrombolytic trials
5. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
6. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
7. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
8. Prognosis of medically stabilized unstable angina pectoris with a negative exercise test
9. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
10. Hypersensitivity of diabetic human platelets to platelet activating factor
11. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo: Evidence derived from the study of peripheral arterial disease
12. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: Evidence for a complex interaction in a multicenter trial
13. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy
14. Will blocking the platelet save the diabetic?
15. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
16. Regression models and life-tables
17. Diabetes and cardiovascular risk factors: The Framingham study
18. Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation
19. Unstable angina: A comparison of angioscopic findings between diabetic and nondiabetic patients
20. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: Natural history and the effect of thrombolysis
21. Abciximab reduces mortality in diabetics following percutaneous coronary intervention